Swedish Orphan Biovitrum Future Growth
Future criteria checks 4/6
Swedish Orphan Biovitrum is forecast to grow earnings and revenue by 25.2% and 9.3% per annum respectively. EPS is expected to grow by 24.6% per annum. Return on equity is forecast to be 14.2% in 3 years.
Key information
25.2%
Earnings growth rate
24.6%
EPS growth rate
Biotechs earnings growth | 38.9% |
Revenue growth rate | 9.3% |
Future return on equity | 14.2% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Recent updates
Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) Earnings Haven't Escaped The Attention Of Investors
Jan 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Jan 11These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jun 26Swedish Orphan Biovitrum (STO:SOBI) Has A Somewhat Strained Balance Sheet
Mar 28Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Nov 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 19An Intrinsic Calculation For Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Suggests It's 50% Undervalued
Aug 12Here's Why Swedish Orphan Biovitrum (STO:SOBI) Has A Meaningful Debt Burden
Jun 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 30,624 | 6,577 | 8,579 | 9,516 | 8 |
12/31/2025 | 27,188 | 4,898 | 7,115 | 7,718 | 10 |
12/31/2024 | 24,511 | 3,332 | 6,288 | 5,935 | 9 |
3/31/2024 | 23,140 | 2,142 | 2,313 | 4,743 | N/A |
12/31/2023 | 22,123 | 2,409 | -473 | 4,470 | N/A |
9/30/2023 | 21,270 | 2,769 | 832 | 5,380 | N/A |
6/30/2023 | 20,100 | 3,125 | 209 | 5,066 | N/A |
3/31/2023 | 19,104 | 3,162 | 337 | 4,915 | N/A |
12/31/2022 | 18,790 | 2,638 | 3,099 | 4,576 | N/A |
9/30/2022 | 17,696 | 2,493 | 3,145 | 4,804 | N/A |
6/30/2022 | 17,458 | 2,516 | 3,363 | 4,317 | N/A |
3/31/2022 | 16,793 | 2,526 | 4,979 | 5,415 | N/A |
12/31/2021 | 15,529 | 2,679 | 5,100 | 5,470 | N/A |
9/30/2021 | 15,214 | 2,940 | 1,405 | 4,066 | N/A |
6/30/2021 | 14,424 | 2,744 | 378 | 4,190 | N/A |
3/31/2021 | 14,283 | 2,759 | 819 | 4,739 | N/A |
12/31/2020 | 15,261 | 3,245 | 1,074 | 4,926 | N/A |
9/30/2020 | 15,570 | 3,103 | 3,101 | 5,185 | N/A |
6/30/2020 | 15,530 | 3,367 | 5,747 | 5,799 | N/A |
3/31/2020 | 15,622 | 3,583 | 5,176 | 5,132 | N/A |
12/31/2019 | 14,248 | 3,304 | -5,171 | 3,634 | N/A |
9/30/2019 | 11,929 | 2,539 | -4,868 | 3,195 | N/A |
6/30/2019 | 11,313 | 2,620 | -6,526 | 2,912 | N/A |
3/31/2019 | 10,440 | 2,806 | -7,233 | 2,201 | N/A |
12/31/2018 | 9,139 | 2,418 | 1,512 | 2,090 | N/A |
9/30/2018 | 8,443 | 2,181 | 1,217 | 1,810 | N/A |
6/30/2018 | 7,729 | 1,881 | 1,589 | 1,678 | N/A |
3/31/2018 | 7,079 | 1,462 | 1,207 | 1,287 | N/A |
12/31/2017 | 6,511 | 1,149 | N/A | 1,333 | N/A |
9/30/2017 | 5,927 | 865 | N/A | 1,103 | N/A |
6/30/2017 | 5,497 | 677 | N/A | 604 | N/A |
3/31/2017 | 5,327 | 703 | N/A | 431 | N/A |
12/31/2016 | 5,204 | 802 | N/A | 343 | N/A |
9/30/2016 | 4,727 | 716 | N/A | 329 | N/A |
6/30/2016 | 4,341 | 585 | N/A | 493 | N/A |
3/31/2016 | 3,636 | 291 | N/A | 573 | N/A |
12/31/2015 | 3,228 | 65 | N/A | 507 | N/A |
9/30/2015 | 3,119 | 59 | N/A | 547 | N/A |
6/30/2015 | 3,000 | 108 | N/A | 426 | N/A |
3/31/2015 | 2,899 | 136 | N/A | 268 | N/A |
12/31/2014 | 2,607 | -268 | N/A | 234 | N/A |
9/30/2014 | 2,513 | -263 | N/A | 185 | N/A |
6/30/2014 | 2,364 | -373 | N/A | 86 | N/A |
3/31/2014 | 2,221 | -410 | N/A | 189 | N/A |
12/31/2013 | 2,177 | -93 | N/A | 185 | N/A |
9/30/2013 | 2,038 | -222 | N/A | 339 | N/A |
6/30/2013 | 1,984 | -211 | N/A | 287 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SOBI's forecast earnings growth (25.2% per year) is above the savings rate (0.9%).
Earnings vs Market: SOBI's earnings (25.2% per year) are forecast to grow faster than the Swedish market (13.5% per year).
High Growth Earnings: SOBI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SOBI's revenue (9.3% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: SOBI's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SOBI's Return on Equity is forecast to be low in 3 years time (14.2%).